Post-earnings recap
Reported
Wed, Apr 29, 2026
EPS actual
$0.99
EPS est.
$1.06
EPS surprise
-7.04%
1-day move
-13.16%
GE HealthCare's earnings report shows a miss on EPS expectations, which may raise concerns among investors about profitability. However, the stock reaction remained unchanged at 0.00%, indicating that investors may have anticipated the results. The lack of revenue data and guidance leaves some uncertainty about future performance, but management's focus on innovation suggests they are looking to improve in the long run.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.99 | $1.05 | -7.04% |
| Revenue | N/A | $5.0B | N/A |
Management expressed cautious optimism about future growth despite missing EPS expectations. They highlighted their commitment to innovation and operational improvements.
Management acknowledged the challenging market conditions affecting earnings.
They emphasized ongoing investments in innovation and efficiency.
GE HealthCare Technologies Inc. operates in the health care sector, focusing on medical equipment and technology. With a market cap of $31 billion, the company plays a crucial role in providing innovative solutions that enhance patient care and streamline healthcare processes.
Last quarter
In Q4-2025, GE HealthCare reported an EPS of $1.44, slightly above estimates, which led to a positive stock reaction of nearly 5% the following day. However, revenue figures were not disclosed.
EPS beat streak
1Q
EPS beat rate
88%
Avg EPS surprise
+6.86%
Avg 1-day reaction
+0.99%
Analysts expect GE HealthCare to report solid earnings in Q1-2026, with a consensus EPS of $1.05 and revenue of $5.0 billion. The company has consistently beaten EPS estimates in previous quarters.
Bull case
If GE HealthCare continues its trend of beating earnings expectations, it could see a significant stock price increase, reflecting strong operational performance and market confidence.
Bear case
Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a decline in stock price, especially given the historical volatility around earnings reports.
Key metrics to watch
EPS
$1.05Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.
Revenue
$5.0BTotal revenue reflects the company's ability to generate sales and is vital for assessing growth potential.
The print will turn on these.
Q1
Will GE HealthCare's EPS exceed the consensus estimate of $1.05?
A beat on EPS would reinforce the company's strong performance and could lead to a positive market reaction.
Q2
What guidance will management provide regarding revenue growth?
Investors will closely watch for any forward-looking statements that could impact future performance and stock valuation.
—
Est. EPS
$1.52
Est. Rev
$3.6B
Impl. Move
±39.2%
Why consensus could be wrong
The consensus may underestimate GE HealthCare's ability to leverage recent technological advancements in medical equipment, leading to higher-than-expected revenue growth.
Supporting evidence
The company has consistently beaten EPS estimates, indicating stronger operational efficiency than anticipated.
Options pricing suggests a significant move is expected, reflecting uncertainty that may not be fully captured in current estimates.
Key risk
If revenue growth exceeds $5.1 billion, it could challenge the current consensus outlook.
Pre-commit to what would confirm each case.
This quarter's performance is crucial as it will determine if the company can maintain its growth trajectory amid market uncertainties.
Bull confirmed if
An EPS of $1.07 or higher would confirm the bull case, indicating strong profitability.
Bear confirmed if
An EPS below $0.96 would support the bear case, suggesting potential operational challenges.
What the market is pricing for the move.
Implied Move
±6.12%
Historical Avg
±6.9%
The options market is pricing in a potential stock movement of over 6% following the earnings report, indicating uncertainty among investors.
Options are pricing ±6.1% while GEHC has averaged ±6.9% over the last 8 prints — setup is roughly in line with history.
ATM IV
0.8%
30d HV
32.7%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: 9 of 23 (39%)
This setup has occurred 30 times across Health Care in the last 2 years. 14 of 23 (61%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 6.3%, with a raw directional average of +2.4% (modestly positive historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
94.00%
of float
Insider
0.37%
of float
Holders
1,686
institutions
Top Holders· as of Jun 2026
Dodge & Cox Inc.
37,864,164 sh · $2.4B
8.38%
20.9%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If GE HealthCare beats expectations, history suggests a potential stock increase of around 2.4%, confirming strong operational momentum.
In line / cautious
If results are in line with expectations, the stock may react cautiously, reflecting uncertainty about future growth.
Miss
A miss on earnings could lead to a decline in stock price, with historical averages indicating a potential drop of around 5.8%.
The lines on the call that would change the story.
Blackrock Inc.
37,467,843 sh · $2.4B
8.30%
4.1%
Vanguard Capital Management LLC
29,724,359 sh · $1.9B
6.58%
3.0%
State Street Corporation
20,861,566 sh · $1.3B
4.62%
1.6%
Vanguard Portfolio Management LLC
20,275,526 sh · $1.3B
4.49%
5.7%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.